PETS: financial statements from SEC — TradeAlmanac

PETS

PetMed Express, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Mar 31, 2025
Revenue	179m	227m
Cost of revenue	—	158m
Gross profit	50m	69m
Selling, general and administrative	51m	39m
Operating expenses	109m	71m
Operating income	−59m	−2m
Pre-tax income	−57m	−587,000
Income tax	−73,000	6m
Net income	−57m	−6m
Earnings per share	−2.74	−0.30
Earnings per share, diluted	−2.74	−0.30
Weighted average shares	21m	21m
Weighted average shares, diluted	21m	21m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	21m	27m	36m	41m	55m	50m	52m	46m
Receivables	2m	2m	2m

Cash flow

Metric	Mar 31, 2026	Mar 31, 2025
Operating cash flow	−28m	5m
Depreciation and amortisation	9m	7m
Share-based compensation	1m	−7m
Capital expenditure	5m	5m
Investing cash flow	−5m	−5m
Dividends paid	21,000

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)